Advair Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS ® 250/50 Inhalation Powder/GSK in Healthy Volunteers
Conditions:   Bioequivalence;   Asthma Interventions:   Drug: Test;   Drug: Reference Sponsors:   Respirent Pharmaceuticals Co Ltd.;   BECRO Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2021 Category: Research Source Type: clinical trials

Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation
Conditions:   Stem Cell Transplant Complications;   Respiratory Disease;   Bronchiolitis Obliterans Interventions:   Drug: Seretide;   Drug: Placebo Sponsors:   Assistance Publique - Hôpitaux de Paris;   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2020 Category: Research Source Type: clinical trials